Advertisement

Topics

Trastuzumab Regimen Extends PFS in Rare Endometrial Cancer

11:35 EDT 30 Mar 2018 | OncLive

Adding trastuzumab to chemotherapy increased progression-free survival for patients with advanced HER2/neu-positive uterine serous carcinoma,

Original Article: Trastuzumab Regimen Extends PFS in Rare Endometrial Cancer

NEXT ARTICLE

More From BioPortfolio on "Trastuzumab Regimen Extends PFS in Rare Endometrial Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...